[1] |
Torre L A, Bray F, Siegel RL,et al. Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(2):87-108.
|
[2] |
Chen W, Zheng R, Baade PD,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
|
[3] |
Chen K, Chen G, Wang H,et al. Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial[J]. J Hepatol,2014,61(6):1304-1311.
|
[4] |
Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours[J]. Cardiovasc Intervent Radiol,2010,33(1):11-17.
|
[5] |
Lee MW. Comments on "Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?"[J]. Radiology,2010,254(2):633; author reply 634.
|
[6] |
European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol,2012,56(4):908-943.
|
[7] |
Seror O, N'Kontchou G, Ibraheem M,et al. Large(>or=5.0-cm)HCCs: multipolar RF ablation with three internally cooled bipolar electrodes-initial experience in 26 patients[J]. Radiology,2008,248(1):288-296.
|
[8] |
Tateishi R, Shiina S, Akahane M,et al. Frequency,risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma[J]. PLoS ONE,2013,8(4):e59040.
|
[9] |
Peng ZW, Zhang YJ, Chen MS,et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial[J]. J Clin Oncol,2013,31(4):426-432.
|
[10] |
Dohmen K, Shirahama M, Shigematsu H,et al. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate[J]. Hepatogastroenterology,2001,48(41):1409-1415.
|
[11] |
Kim JH, Won HJ, Shin YM,et al. Medium-sized(3.1-5.0 cm)hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone[J]. Ann Surg Oncol,2011,18(6):1624-1629.
|
[12] |
Morimoto M, Numata K, Kondou M,et al. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization[J]. Cancer,2010,116(23):5452-5460.
|
[13] |
Ji J, Gao J, Zhao L,et al. Computed tomography-guided radiofrequency ablation following transcatheter arterial embolization in treatment of large hepatic hemangiomas[J]. Medicine(Baltimore),2016,95(15):e3402.
|
[14] |
Ji J, Gao J, Zhao L,et al. Computed Tomography-Guided Radiofrequency Ablation Following Transcatheter Arterial Embolization in Treatment of Large Hepatic Hemangiomas[J]. Medicine,2016,95(15):e3402.
|
[15] |
Guo YJ, Huang WS, Zhou B et al. Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations[J]. Zhonghua Yi Xue Za Zhi,2013,93(33):2627-2630.
|
[16] |
Toshimori J, Nouso K, Nakamura S,et al. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location[J]. Acta Med Okayama,2015,69(4):219-226.
|
[17] |
Chen L, Sun J, Yang X. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status[J]. Cancer Lett,2016,370(1):78-84.
|
[18] |
Sakr AA, Saleh AA, Moeaty AA,et al. The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma[J]. Eur J Radiol,2005,54(3):418-425.
|
[19] |
Li Z, Zhang K, Lin SM,et al. Radiofrequency ablation combined with percutaneous ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Int J Hyperthermia,2016:1-10.
|
[20] |
Zhu ZX, Liao MH, Wang XX,et al. Radiofrequency ablation with or without ethanol injection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Minerva Med,2016,107(6):381-391.
|
[21] |
Wong SN, Lin CJ, Lin CC,et al. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations[J]. AJR Am J Roentgenol,2008,190(3):W187-W195.
|
[22] |
Kurokohchi K, Watanabe S, Masaki T,et al. Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma[J]. World J Gastroenterol,2005,11(10):1426-1432.
|
[23] |
Kurokohchi K, Masaki T, Watanabe S,et al. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma[J]. Int J Oncol,2006,28(4):971-976.
|
[24] |
Shrimal A, Prasanth M, Kulkarni AV. Interventional radiological treatment of hepatocellular carcinoma: an update[J]. Indian J Surg,2012,74(1):91-99.
|
[25] |
Boerman OC, Koppe MJ, Postema EJ,et al. Radionuclide therapy of cancer with radiolabeled antibodies[J]. Anticancer Agents Med Chem,2007,7(3):335-343.
|
[26] |
Tu J, Ji J, Wu F,et al. Effectiveness of combined(131)I-chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinoma[J]. Cell Biochem Biophys,2015,71(2):777-784.
|
[27] |
Rousse C, Chauvet B. Recommendations for inspections of the French nuclear safety authority[J]. Cancer Radiother,2015,19(6-7):634-637.
|
[28] |
Zhongmin W, Yu L, Fenju L,et al. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer[J]. European Radiology,2010,20(7):1786-1791.
|
[29] |
Li C, Zhang F, Zhang W,et al. Feasibility of(125)I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma[J]. J Cancer Res Clin Oncol,2010,136(11):1633-1640.
|
[30] |
Peng S, Yang QX, Zhang T,et al. Lobaplatin-TACE combined with radioactive 125I seed implantation for treatment of primary hepatocellular carcinoma[J]. Asian Pac J Cancer Prev,2014,15(13):5155-5160.
|
[31] |
Tu JF, Xu HH, Ying XH,et al. Comparative study of several microinvasive treatments for large hepatocellular carcinoma[J]. Eur Rev Med Pharmacol Sci,2015,19(1):45-53.
|
[32] |
Santambrogio R, Chiang J, Barabino M,et al. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma(≤3 cm)[J]. Ann Surg Oncol,2017,24(1):257-263.
|
[33] |
Ginsburg M, Zivin SP, Wroblewski K,et al. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation[J]. J Vasc Interv Radiol,2015,26(3):330-341.
|
[34] |
Vogl TJ, Farshid P, Naguib NN,et al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation[J]. Abdom Imaging,2015,40(6):1829-1837.
|
[35] |
Lencioni R, de Baere T, Martin RC,et al. Image-guided ablation of malignant liver tumors: Recommendations for clinical validation of novel thermal and non-thermal technologies-a western perspective[J]. Liver Cancer,2015,4(4):208-214.
|
[36] |
de Baere T, Deschamps F. New tumor ablation techniques for cancer treatment(microwave,electroporation)[J]. Diagn Interv Imaging,2014,95(7-8):677-682.
|
[37] |
Sheta E, El-Kalla F, El-Gharib M,et al. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study[J]. Eur J Gastroenterol Hepatol,2016,28(10):1198-1203.
|
[38] |
Lee KF, Wong J, Hui JW,et al. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study[J]. Asian J Surg,2017,40(4):301-308.
|
[39] |
Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis[J]. Int J Hyperthermia,2016,32(3):339-344.
|
[40] |
Ierardi AM, Floridi C, Fontana F,et al. Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation[J]. Radiol Med,2013,118(6):949-961.
|
[41] |
Correa-Gallego C, Fong Y, Gonen M,et al. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases[J]. Ann Surg Oncol,2014,21(13):4278-4283.
|
[42] |
Zhou Y, Zhao Y, Li B,et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma[J]. BMC Gastroenterol,2010,10:78.
|
[43] |
Choi D, Lim HK, Rhim H,et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series[J]. Eur Radiol,2007,17(3):684-692.
|
[44] |
Choi D, Lim HK, Joh JW,et al. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors[J]. Ann Surg Oncol,2007,14(12):3510-3518.
|
[45] |
Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas[J]. World J Gastrointest Surg,2010,2(4):137-142.
|